[Long-term survivors of non-small cell lung cancer treated with non-surgical therapeutic modalities].
Of 225 patients with a non-small cell lung cancer treated with non-surgical therapeutic modalities, 21 patients (9.3%) survived for two years and more. The performance status and weight loss were important prognostic factors. There was no relation between response to treatment and long-term survival in patients with an adenocarcinoma. All two-year survivors with a squamous cell carcinoma achieved a complete response or a partial response with non-surgical treatment. It is considered that improving response rate with a combined non-surgical modality treatment, including a combination of chemotherapy and radiotherapy is important to obtain a long-term survival for those with a non-small cell lung cancer, excepting those determined to have an adenocarcinoma.
Fujii
M
M
Dept. of Int. Med., Shikoku Cancer Center Hospital.
Segawa
Y
Y
Matsutomo
S
S
Kimura
M
M
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012074:Remission Induction; D015996:Survival Rate